Current Clinical Research of Acute Kidney Injury in China

Bi-Cheng Liu,Ri-Ning Tang,Zhi-Hong Liu
DOI: https://doi.org/10.4103/0366-6999.156148
2015-01-01
Abstract:IntroductIon Acute kidney injury (AKI) is a common clinical syndrome characterized by an abrupt decline of renal function and has been recognized as a major healthcare problem affecting millions of patients worldwide. AKI is strongly associated with increased resource utilization, mortality, and risk for the development of chronic kidney disease (CKD).[1‐3] In the past decade, a number of definitions regarding AKI (including Risk Injury Failure Loss End‐Stage Renal Disease [RIFLE], Acute Kidney Injury Network [AKIN], Kidney Disease Improving Global Outcomes [KIDGO]) have been published, which greatly stimulated the epidemiologic and clinical study of AKI throughout the world. With 1.3 billion people, China is the largest developing country in the world. Although the nationwide community‐based survey on the incidence rate of AKI in China is still not available, a number of studies for specific patient groups (such as hospitalized patients, Intensive Care Unit [ICU] patients or children) have been conducted. The present study will evaluate the epidemiology, etiology, and current status of the diagnosis and treatment of AKI in China.
What problem does this paper attempt to address?